(19)
(11) EP 0 879 279 A1

(12)

(43) Date of publication:
25.11.1998 Bulletin 1998/48

(21) Application number: 97905834.0

(22) Date of filing: 06.02.1997
(51) International Patent Classification (IPC): 
C12N 15/ 09( . )
A61K 38/ 00( . )
A61P 3/ 10( . )
C12N 5/ 10( . )
A61K 35/ 76( . )
A61K 48/ 00( . )
C07K 14/ 605( . )
(86) International application number:
PCT/US1997/001978
(87) International publication number:
WO 1997/029180 (14.08.1997 Gazette 1997/35)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
Designated Extension States:
RO

(30) Priority: 06.02.1996 US 19960012111P
23.02.1996 GB 19960003847

(71) Applicant: ELI LILLY AND COMPANY
Indianapolis, Indiana 46285 (US)

(72) Inventors:
  • BORTS, Tracy, L.
    Indianapolis, IN 46220 (US)
  • BRODERICK, Carol, L.
    Monrovia, IN 46157 (US)
  • DIMARCHI, Richard, D.
    Carmel, IN 46033 (US)
  • GRINNELL, Brian, W.
    Indianapolis, IN 46220 (US)
  • MILLER, Anne, R.
    Indianapolis, IN 46208 (US)

(74) Representative: Denholm, Anna Marie, et al 
Eli Lilly and Company Limited, Lilly Research Center, Erl Wood Manor
Windlesham, Surrey GU20 6PH
Windlesham, Surrey GU20 6PH (GB)

   


(54) DIABETES THERAPY